Pilot Research regarding an appropriate bolus dosage of intermittent epidural analgesia

Pilot Research regarding an appropriate bolus dosage of intermittent epidural analgesia - ADIEA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018927

Enrollment

Registered

2015-09-15

Start date

2015-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients of liver disease with open liver resection requiring epidural analgesia

Interventions

Appropriate dosage of intermittent epidural analgesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with acquired consent 2) Conscious patients enable to do the conversation

Exclusion criteria

Exclusion criteria: 1) allergy for analgesics 2) Renal dysfunction (Serum Creatinin 2.0 mg/dL) 3) Liver dysfunction (Serum AST/ALT >100 mg/dL) 4) Severe Heart dysfunction (Ejection fraction <40%) 5) Patients with convulsion 6) Severe asthma 7) Difficult procedure of epidural analgesia

Design outcomes

Primary

Measure	Time frame
We will investigate the good pain control without side effects.	—

Secondary

Measure	Time frame
The information regarding pump usage of analgesia and frequency of bolus and request. The information of other analgegics	—

Countries

Japan

Contacts

Public ContactTakashi Matsusaki

OKAYAMA UNIVERSITY HOSPITAL Intensive Care Unit

matusakik@ybb.ne.jp086-235-7778

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026